Hemophilia and Bleeding Disorder Drug Program

Managing hemophilia and bleeding disorders is a complex process involving a rigorous and expensive regimen of specialty drugs. The high cost of these drugs can be a key barrier to care for patients with these conditions.

Highmark is taking action to help manage the cost of these drugs through the hemophilia and bleeding disorder drug program.

Exclusive Specialty providers that will be the exclusive locations that will be providers of the drugs:

  1. Option Care Health (specialty pharmacy and home infusion provider)
  2. Soleo Health (specialty pharmacy and home infusion provider)
  3. Hemophilia Center of Pennsylvania (hemophilia treatment center located in Pittsburgh, PA)

These providers have access to all hemophilia drugs and ability to treat members in all states. These are self-administered drugs, so there is no need for member coordination in terms of physical locations where these drugs are obtained.

Alignment of Benefits

Historically, Highmark has covered hemophilia and bleeding disorder drugs under members’ medical benefits.

Effective January 1, 2020, Highmark will shift hemophilia and bleeding disorder drugs under members’ pharmacy benefits because these drugs are self-administered and more appropriate for the pharmacy benefit.

List of Drugs included in program

Contact Info

Contact the specialty pharmacies at the following numbers:

  • Option Care: 833-431-0001
  • Soleo: 844-787-2020
  • Hemophilia Center of Pennsylvania 412-209-7280

For general questions, contact Provider Service.

Last updated on 11/8/2019 10:42:23 AM


To Top